Aviance Capital Management’s AbbVie ABBV Stock Holding History

Aviance Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$73K	Sell	905 -85,716	-99%	-$7.01M	0.01%	175
2018 Q4	$7.99M	Buy	86,621 +86,548	+118,559%	+$7.61M	1.12%	27
2018 Q3	$7K	Sell	73 -21	-22%	-$1.99K	﹤0.01%	190
2018 Q2	$9K	Sell	94 -104,686	-100%	-$10.2M	﹤0.01%	183
2018 Q1	$9.92M	Sell	104,780 -38,941	-27%	-$4.28M	0.76%	32
2017 Q4	$13.9M	Sell	143,721 -22,886	-14%	-$2.16M	0.99%	24
2017 Q3	$14.8M	Sell	166,607 -16,486	-9%	-$1.25M	1.02%	25
2017 Q2	$13.3M	Sell	183,093 -23,247	-11%	-$1.56M	0.83%	31
2017 Q1	$13.4M	Buy	+206,340	New	+$13M	0.75%	39
2016 Q4	–	Sell	-547,056	Closed	-$34.5M	–	190
2016 Q3	$34.5M	Buy	547,056 +181,876	+50%	+$11.8M	0.96%	29
2016 Q2	$22.6M	Buy	365,180 +90,854	+33%	+$5.54M	0.68%	43
2016 Q1	$15.7M	Buy	274,326 +260,854	+1,936%	+$14.5M	0.52%	57
2015 Q4	$798K	Buy	13,472 +2,436	+22%	+$140K	0.03%	181
2015 Q3	$600K	Buy	+11,036	New	+$718K	0.02%	187
2014 Q3	–	Sell	-25,985	Closed	-$1.47M	–	284
2014 Q2	$1.47M	Buy	25,985 +6,195	+31%	+$325K	0.06%	139
2014 Q1	$1.02M	Sell	19,790 -34,684	-64%	-$1.75M	0.05%	144
2013 Q4	$2.88M	Sell	54,474 -3,111	-5%	-$153K	1.53%	15
2013 Q3	$2.58M	Sell	57,585 -2,252	-4%	-$99.8K	1.5%	15
2013 Q2	$2.47M	Buy	+59,837	New	+$2.62M	1.36%	12

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Aviance Capital Management's ABBV Position: Q1 2019 in Review

Aviance Capital Management reduced its AbbVie (ABBV) stake by 99% in Q1 2019, selling an estimated $7.01M and leaving 905 shares worth $73K. The position accounts for 0.01% of the portfolio, ranked #175.

Aviance Capital Management first reported a position in ABBV in Q2 2013 and has held it in 19 quarters since. The position peaked at $34.5M in Q3 2016. 2,034 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.

Aviance Capital Management held 905 shares of AbbVie worth $73K as of Q1 2019.
Aviance Capital Management sold 85,716 AbbVie shares in Q1 2019, an estimated $7.01M.
AbbVie made up 0.01% of Aviance Capital Management's portfolio in Q1 2019, its #175 holding.
Aviance Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 19 quarters since.
Aviance Capital Management's AbbVie position peaked at $34.5M in Q3 2016.
2,034 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.

Based on Aviance Capital Management's 13F filing for Q1 2019, filed 15 May 2019.